Keith M. Gehl Acquires 403 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) Director Keith M. Gehl acquired 403 shares of the stock in a transaction dated Tuesday, March 18th. The shares were bought at an average cost of $49.00 per share, for a total transaction of $19,747.00. Following the acquisition, the director now owns 17,000 shares in the company, valued at $833,000. The trade was a 2.43 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.

Kewaunee Scientific Stock Performance

KEQU opened at $49.49 on Friday. The firm has a market capitalization of $142.14 million, a P/E ratio of 7.84 and a beta of 0.71. The stock’s 50 day moving average price is $57.69 and its two-hundred day moving average price is $47.80. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a 12-month low of $30.82 and a 12-month high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last released its earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. The firm had revenue of $67.17 million for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Institutional Trading of Kewaunee Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KEQU. Bank of America Corp DE grew its holdings in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after buying an additional 443 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Kewaunee Scientific by 18,000.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after acquiring an additional 900 shares during the period. IFP Advisors Inc bought a new stake in shares of Kewaunee Scientific in the 4th quarter worth approximately $36,000. Morgan Dempsey Capital Management LLC bought a new stake in shares of Kewaunee Scientific in the 4th quarter worth approximately $106,000. Finally, Barclays PLC bought a new stake in shares of Kewaunee Scientific in the 3rd quarter worth approximately $121,000. Institutional investors and hedge funds own 32.69% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.